Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses

Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses

US Patent 8835429 · Granted Sep 16, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KHK inhibitors2025
NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic2025
Inhibiting deubiquitinase USP25 and USP282025
Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum 2025
Bicyclic-fused heteroaryl or aryl compounds2025
Substituted pyrrolizine compounds and uses thereof2024
Activating pyruvate kinase R2024
Activating pyruvate kinase R2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators2024
Treating sickle cell disease with a pyruvate kinase R activating compound2024
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives2024
LPA receptor antagonists and uses thereof2024